CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 471851754
- Phone
- 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- 4 Grant or award Director acquired 7,768 shares (grant or award)
- 4 Grant or award Director acquired 7,768 shares (grant or award)
- 4 Grant or award Director acquired 7,768 shares (grant or award)
- 4 Grant or award Director acquired 7,768 shares (grant or award)
- 4 Grant or award Director acquired 7,768 shares (grant or award)
- 4 Grant or award Director acquired 7,768 shares (grant or award)
- 4 Grant or award Director acquired 7,768 shares (grant or award)
- 4 Grant or award Director acquired 7,768 shares (grant or award)
- 8-K Event Shareholder vote results
- 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
- 4 Planned sale Director sold 20,602 shares at $7.91 ($163,046)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- EFFECT Other Notice of Effectiveness
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes Chief Legal Officer gave up 4,700 shares (to pay taxes)
Page 6 of 41 · 806 filings